• Users Online: 45
  • Home
  • Print this page
  • Email this page
Year : 2022  |  Volume : 12  |  Issue : 1  |  Page : 18-23

Effect of an ionic antineoplastic agent Cytoreg on blood chemistry in a Wistar rat model

1 Biochemistry Laboratories, Department of Pathology, University of the Andes, Mérida, Venezuela
2 Department of Biology, Faculty of Science, University of the Andes, Mérida, Venezuela
3 Vivarium, University of the Andes, Mérida, Venezuela
4 Department of Technical and Experimental Surgery, Faculty of Medicine, University of the Andes, Mérida, Venezuela
5 Vitalis, Clinical Laboratory, Smart Health Laboratory, Merida, Venezuela
6 Cytorex de Venezuela SA, Maracaibo, Venezuela
7 Cytorex Biosciences, Inc., Weston, FL, USA

Correspondence Address:
Katiusca Villasana
Biochemistry Laboratories, Department of Pathology, University of the Andes, Mérida
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/2045-9912.324592

Rights and Permissions

Cytoreg is an ionic therapeutic agent comprising a mixture of hydrochloric, sulfuric, phosphoric, hydrofluoric, oxalic, and citric acids. In diluted form, it has demonstrated efficacy against human cancers in vitro and in vivo. Although Cytoreg is well tolerated in mice, rats, rabbits, and dogs by oral and intravenous administration, its mechanism of action is not documented. The acidic nature of Cytoreg could potentially disrupt the pH and levels of ions and dissolved gases in the blood. Here, we report the effects of the intravenous administration of Cytoreg on the arterial pH, oxygen and carbon dioxide pressures, and bicarbonate, sodium, potassium, and chloride concentrations. Our results demonstrate that Cytoreg does not disturb the normal blood pH, ion levels, or carbon dioxide content, but increases oxygen levels in rats. These data are consistent with the excellent tolerability of intravenous Cytoreg observed in rabbits, and dogs. The study was approved by the Bioethics Committee of the University of the Andes, Venezuela (CEBIOULA) (approval No. 125) on November 3, 2019.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded274    
    Comments [Add]    
    Cited by others 1    

Recommend this journal